Cargando…

An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis

Pulmonary fibrosis (PF) is a heterogeneous disease with a poor prognosis. Therefore, identifying additional therapeutic modalities is required to improve outcome. However, the lack of biomarkers of disease progression hampers the preclinical to clinical translational process. Here, this work assesse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arif, Muhammad, Basu, Abhishek, Wolf, Kaelin M., Park, Joshua K., Pommerolle, Lenny, Behee, Madeline, Gochuico, Bernadette R., Cinar, Resat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238219/ https://www.ncbi.nlm.nih.gov/pubmed/37038090 http://dx.doi.org/10.1002/advs.202207454

Ejemplares similares

Hermansky–Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease
por: Yokoyama, Tadafumi, et al.
Publicado: (2021)

Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndrome
por: Abudi-Sinreich, Shachar, et al.
Publicado: (2022)

Chronic and Binge Alcohol Ingestion Increases Truncated Oxidized Phosphatidylcholines in Mice Lungs Due to Increased Oxidative Stress
por: Appolonia, Corynn N., et al.
Publicado: (2022)

CB(1)R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome
por: Cinar, Resat, et al.
Publicado: (2021)

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases
por: Tanguy, Julie, et al.
Publicado: (2021)

The Immunome in Two Inherited Forms of Pulmonary Fibrosis
por: El-Chemaly, Souheil, et al.
Publicado: (2018)

Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
por: Wilson, Mark S., et al.
Publicado: (2010)

Synthetic lethality: a framework for the development of wiser cancer therapeutics
por: Kaelin, William G
Publicado: (2009)

Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens
por: Testa, Lauren C., et al.
Publicado: (2021)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Peripheral Hybrid CB(1)R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis
por: Zawatsky, Charles N., et al.
Publicado: (2021)

The Essentials of Multiomics
por: Marshall, John L, et al.
Publicado: (2022)

MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Rosas, Ivan O, et al.
Publicado: (2008)

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
por: Yao, Lijun, et al.
Publicado: (2023)

Mononuclear Phagocytes and Airway Epithelial Cells: Novel Sources of Matrix Metalloproteinase-8 (MMP-8) in Patients with Idiopathic Pulmonary Fibrosis
por: Craig, Vanessa J., et al.
Publicado: (2014)

Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis
por: Kirshenbaum, Arnold S., et al.
Publicado: (2016)

Multiomics Analysis of Genetics and Epigenetics Reveals Pathogenesis and Therapeutic Targets for Atrial Fibrillation
por: Liu, Li, et al.
Publicado: (2021)

Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
por: Wu, Alexander T. H., et al.
Publicado: (2021)

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach
por: Advani, Dia, et al.
Publicado: (2021)

Multiomic prediction of therapeutic targets for human diseases associated with protein phase separation
por: Lim, Christine M., et al.
Publicado: (2023)

Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape
por: Gui, Chengpeng, et al.
Publicado: (2023)

Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation
por: El-Chemaly, Souheil, et al.
Publicado: (2018)

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
por: Zeybel, Mujdat, et al.
Publicado: (2022)

Embracing Integrative Multiomics Approaches
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Multiomic immune clockworks of pregnancy
por: Peterson, Laura S., et al.
Publicado: (2020)

Novel therapeutic approaches for pulmonary fibrosis
por: Datta, Arnab, et al.
Publicado: (2011)

Therapeutic Potential of Exosomes in Pulmonary Fibrosis
por: Xie, Linshen, et al.
Publicado: (2020)

Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension—A pilot study
por: Siddaiah, Roopa, et al.
Publicado: (2023)

SCRaPL: A Bayesian hierarchical framework for detecting technical associates in single cell multiomics data
por: Maniatis, Christos, et al.
Publicado: (2022)

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
por: Su, Guan-Hua, et al.
Publicado: (2023)

Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
por: Zawatsky, Charles N., et al.
Publicado: (2020)

Multiomics kaleidoscope to visualize cancer hallmarks
por: Zhou, Shengtao
Publicado: (2020)

Multiview learning for understanding functional multiomics
por: Nguyen, Nam D., et al.
Publicado: (2020)

Potential of multiomics technology in precision medicine
por: Putignani, Lorenza, et al.
Publicado: (2019)

Tendon and multiomics: advantages, advances, and opportunities
por: Sarmiento, Paula, et al.
Publicado: (2021)

Recent Multiomics Approaches in Endometrial Cancer
por: Boroń, Dariusz, et al.
Publicado: (2022)

The role of physics in multiomics and cancer evolution
por: Gourmet, Lucie E., et al.
Publicado: (2023)

Multiomic Investigations into Lung Health and Disease
por: Blutt, Sarah E., et al.
Publicado: (2023)

Plant biochemical genetics in the multiomics era
por: Alseekh, Saleh, et al.
Publicado: (2023)

Considerations for therapeutic intervention models of pulmonary fibrosis
por: Wilder, JA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pmnh1gt87ii0h0i1h9r3bopadt